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Dominance hierarchies are integral aspects of social groups, yet
whether personality traits may predispose individuals to a particular
rank remains unclear. Here we show that trait anxiety directly
influences social dominance in male outbred rats and identify an
important mediating role for mitochondrial function in the nucleus
accumbens. High-anxious animals that are prone to become sub-
ordinate during a social encounter with a low-anxious rat exhibit
reduced mitochondrial complex I and II proteins and respiratory
capacity as well as decreased ATP and increased ROS production in
the nucleus accumbens. A causal link for these findings is indicated by
pharmacological approaches. In a dyadic contest between anxiety-
matched animals, microinfusion of specific mitochondrial complex I or
II inhibitors into the nucleus accumbens reduced social rank, mimick-
ing the low probability to become dominant observed in high-
anxious animals. Conversely, intraaccumbal infusion of nicotinamide,
an amide form of vitamin B3 known to enhance brain energy
metabolism, prevented the development of a subordinate status in
high-anxious individuals. We conclude that mitochondrial function in
the nucleus accumbens is crucial for social hierarchy establishment
and is critically involved in the low social competitiveness associated
with high anxiety. Our findings highlight a key role for brain energy
metabolism in social behavior and point to mitochondrial function in
the nucleus accumbens as a potential marker and avenue of treat-
ment for anxiety-related social disorders.
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social competition
In most socially living species, the social rank of an individual isestablished during competitive encounters with conspecifics. The
outcome of these encounters determines the allocation of territory,
resources and access to reproduction (1), and greatly influences
physiology and health (2). Winning a social competition is rewarding,
enhances rank in social hierarchies, and increases the probability of
winning future contests (3, 4). In contrast, losing a social encounter
typically undermines one’s social rank. In humans, a low social status
predicts morbidity and survival (5) and has also been linked to the
development of psychopathologies (6). Despite the important con-
sequences of social rank on health, little is known regarding the
mechanisms underlying the establishment of social hierarchies.
One of the main reasons for the paucity of neurobiological
mechanisms determining social hierarchies may be that social com-
petition involves interacting subjects that both need to be taken into
account. The competitors may exhibit different features such as size,
age, gender, as well as previous social experience, all known to in-
fluence social competitiveness. However, when subjects are matched
for these characteristics, the impact of innate personality traits on
social competitiveness may be investigated. One such personality
trait, anxiety, may have important consequences for the outcome of
social competitions. In humans, high-anxious individuals often dis-
play a subordinate status and report feelings of being overlooked and
rejected (7), and their competitive self-confidence becomes under-
mined under stress (8). Thus, interindividual differences in anxiety
could predetermine the outcome of a competitive encounter and,
as such, trait anxiety may have important consequences for social
status. However, the neural mechanisms whereby anxiety might
affect social hierarchy formation are largely unknown.
We addressed this question by examining social competitiveness
between male rats characterized for trait anxiety. Recent work has
highlighted the potential for individual differences in mitochondrial
function and, more broadly, energy metabolism to influence vul-
nerability to develop psychopathological disorders, such as anxiety
and depression (9–14). Here, we demonstrate that trait anxiety is a
determining factor of social rank that is mediated by brain region-
specific mitochondrial function. We show that manipulation of
mitochondrial function in the nucleus accumbens (NAc) is sufficient
to influence social rank, highlighting a key role for brain mitochondrial
function in social behavior.
Results
High Trait Anxiety Is a Predisposing Factor to Social Subordination.
To establish the relationship between anxiety and the outcome of a
social competition, male outbred rats were first classified as high-,
intermediate-, or low-anxious based on natural variation for anxiety-
like behavior on the elevated plus maze (Fig. 1 A–C and
SI Appendix, Fig. S1A). Their anxiety profiles were confirmed in
another validated test for anxiety, the light–dark box (Fig. 1 D and E
and SI Appendix, Fig. S1 B–D). Then, high-anxious and low-anxious
rats were matched for body weight, age, and social experience, and
allowed to compete for a new territory. High-anxious rats exhibited
reduced offensive behavior during the social encounter (Fig. 1F and
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SI Appendix, Fig. S1 E–G), which is reflected by a social dominance
level below chance (50%, Fig. 1G). Importantly, the subordinate
character of high-anxious rats was not apparent from the onset of the
interaction, but developed throughout the social encounter, in-
dicating no lack of motivation to compete in these animals (Fig. 1H).
The low competitive success of high-anxious rats was also evident
during a subsequent encounter that took place 1 wk later (Fig. 1G),
emphasizing the pervasive impact of anxiety on social rank. To ex-
amine whether this anxiety-related difference in social competitive-
ness was related to “social anxiety,” we performed a follow-up study
of social preference and found that both high- and low-anxious rats
similarly exhibited a preference to explore a juvenile rat over an
inanimate object (Fig. 1I). Thus, the differences in social competi-
tiveness are not related to overall differences in social motivation or
sociability. Because self-confidence is affected by stress (8), we in-
vestigated whether differences in the stress response might explain
the low competitive success of high-anxious rats. We examined
corticosterone levels in high- and low-anxious rats under basal
conditions and following social competition. Although social
competition did significantly increase corticosterone compared
with baseline levels, there were no significant differences between
anxiety groups at either time point (SI Appendix, Fig. S1H).
The Nucleus Accumbens Is Critically Involved in the Establishment of a
Social Hierarchy. Several brain regions [e.g., the prefrontal cortex
(15), NAc (16), and the amygdala (17, 18)] have been involved in
the establishment of social hierarchies in rodents, with the ventral
striatum (including the NAc) being consistently highlighted in hu-
man imaging studies of social status (19, 20) and competition (21).
We confirmed the activation of the nucleus accumbens (along with
that of the prefrontal cortex and basolateral, but not central, nu-
cleus of the amygdala) following a social competition test, in both
low- and high-anxious naïve animals by comparing the expression of
the immediate early transcription factor gene zif-268 mRNA fol-
lowing the encounter to basal conditions (Fig. 1J). We next
aimed to test the causal involvement of the NAc and BLA in the
establishment of a dominant rank. For this purpose, we performed
independent experiments in which we pharmacologically inacti-
vated each of these brain areas through microinfusion of muscimol,
a GABAA receptor agonist, 30 min before social competition be-
tween two males matched for equivalent anxiety levels. Upon
muscimol infusion in the NAc, rats exhibited reduced social dom-
inance levels in a confrontation with another anxiety-matched male
that was infused with vehicle (Fig. 1K). Importantly, this treatment
did not induce changes in locomotor activity as evaluated in the
open field (SI Appendix, Fig. S1I). On the contrary, inactivation of
the basolateral amygdala (BLA) with muscimol had no impact on
the social hierarchy outcome (Fig. 1K). We validated the effec-
tiveness of our BLA treatment by demonstrating that it drastically
inhibited fear conditioning (SI Appendix, Fig. S2), confirming the
role of the BLA in this type of behavior (22). Given the prominent
role of the NAc in social competition, we performed an additional
experiment to gain insight into the cell types which show activation
in this nucleus following a competitive encounter. Double-labeling
of cFOS with markers for several neuronal types highlighted a
significant activation of substance P-containing cells [known to
represent medium spiny neurons (MSNs) containing the dopami-
nergic receptor D1 (23)] following social competition (Fig. 2 A and
B) that correlated with the amount of competitive behavior (Fig.
2C). However, no social challenge-induced significant activations
were observed for cholinergic cells, for cells containing enkephalin
[known to represent D2-containing MSNs (23)] or for cells con-
taining the S100 astrocytic marker (SI Appendix, Fig. S3 A–F).
Therefore, these data point to the involvement of accumbal D1-
containing MSNs in social competition.
High-Anxious Rats Exhibit Reduced Mitochondrial Function in the NAc.
As our findings pointed to a prominent role of the NAc in social
competition, we explored potential molecular pathways within the
NAc differing between high- and low-anxious rats. We started by
examining differential basal gene expression between high- and
low-anxious rats in the NAc using microarrays and gene set
Fig. 1. High anxiety predisposes for social submission. (A) Classification for anxiety-profiles was based on the elevated plus maze (EPM; HA, high-anxious; IA,
intermediate-anxious; LA, low-anxious). Time spent in the open arm of the EPM (B and C) and in the lit compartment of the light–dark test (D and E) was
lower for HA animals, n = 24 per group. When competing against an LA rat, HA rats display reduced offensive behavior (F) and show low social dominance
(G) emerging throughout time (H), n = 24 pairs. (I) Both HA and LA rats display similar levels of social preference. (J) Levels of zif268 were increased following
social competition in the nucleus accumbens (NAc), prefrontal cortex (PFC), and basolateral (BLA), but not central (CeA), amygdala in both groups, n = 10–20
per group. (K) Local inactivation with muscimol in the NAc, but not BLA, reduced social dominance, n = 11–13 pairs. Data are mean ± SEM (*P < 0.05,
**P < 0.01, ***P < 0.001, Student’s t test or one-sample t test against chance, 50%, level).
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enrichment analysis (GSEA). The top regulated biological
processes in high- versus low-anxious rats involved metabolic
functions at various cellular levels (SI Appendix, Fig. S4A) and
GSEA analysis on a curated set of mitochondrial genes pointed to
significant differences in genes enriched in categories related to
mitochondrial function (SI Appendix, Fig. S4B and Table S1). Mi-
tochondrial respiratory function is essential for neural processing, as
it plays key roles in many essential functions required for neural
homeostasis and computations (24–26). Thus, we reasoned that the
disadvantage of high-anxious rats to win the competition against low-
anxious rats could reflect a lower mitochondrial activity in the NAc.
We first measured protein levels in the five mitochondrial complexes
that comprise the electron transport chain between high- and low-
anxious rats. In both complexes I and II, starting points for mito-
chondrial respiration, high-anxious rats exhibited lower levels of
protein than low-anxious rats (Fig. 3A). We then examined whether
such protein differences might be indicative of a difference in mi-
tochondrial number. However, both PCR analysis of mitochondrial
DNA levels (Fig. 3B), and mitochondrial quantification from im-
ages obtained with transmission electron microscopy (SI Appendix,
Table S2) revealed no significant differences in mitochondrial
number or density in the NAc between high- and low-anxious rats,
indicating that the observed differences in complex I and II
protein content are not due to a sheer difference in mitochondrial
number but to an enrichment in these respiratory complexes per
mitochondria.
Accordingly, we next evaluated whether mitochondrial func-
tion in the NAc differed between high- and low-anxious rats.
Using high-resolution respirometry, we found that when coupled
respiration through complex I was stimulated in NAc homoge-
nates by the addition of ADP, low-anxious rats displayed higher
respiration rates than those of high-anxious rats, a difference
that became more prominent upon complex II stimulation.
Maximal electron transport system capacity (ETS) was also
markedly higher in the NAc from low-anxious rats. Finally, the
addition of rotenone revealed higher maximal respiration due to
complex II activity (Fig. 3C). Linear regression analysis identi-
fied significant correlations between anxiety-like behavior on the
elevated-plus maze and respiration levels following stimulation
of complex II, ETS, and rotenone addition (SI Appendix, Fig. S5
A–D). The reduced mitochondrial respiratory capacity in the
NAc of high-anxious animals is persistent in life, as it was also
present when measured two months after anxiety characteriza-
tion (Fig. 3D), fitting with the observed differences at the protein
level (Fig. 3A). The addition of cytochrome c to the NAc prepa-
rations confirmed that the reported differences are not due to a
differential mitochondrial vulnerability during experimental prepa-
ration (SI Appendix, Fig. S6A). Likewise, the anxiety-related effect
on mitochondrial function was not a result of putative differences
in body size, locomotor activity, or food intake, as these were
equivalent for both high- and low-anxious animals (SI Appen-
dix, Fig. S6 B–D). To investigate the specificity of these findings
for the NAc, we examined mitochondrial respiration in the BLA.
Here, unlike the NAc, high- and low-anxious rats displayed com-
parable respiration rates in the BLA (Fig. 3E).
We then examined whether the anxiety-related differences in
NAc mitochondrial respiration had functional consequences for
downstream mitochondrial outputs. First, we found that high-anx-
ious animals exhibited significantly lower ATP concentrations in the
NAc than low-anxious counterparts (Fig. 3F). Then, we measured
the levels of a common ROS product in NAc homogenates,
4-Hydroxynonenal [(4-HNE; an α,β-unsaturated hydroxyalkenal
produced by lipid peroxidation, with high levels suggesting increased
periods of oxidative stress (27)] and found higher levels in high-
anxious animals (Fig. 3G).
We then investigated the cellular specificity of the anxiety-related
differences observed in NAc mitochondrial function. We performed
mitochondrial respiration on synaptoneurosomal and glia-enriched
fractions in three independent experiments (Fig. 3H) and found
lower respiration in high-anxious compared with low-anxious ani-
mals in the synaptoneurosomal fraction only (Fig. 3 I–J). This
finding is consistent with the lack of astrocytic activation induced by
social competition (SI Appendix, Fig. S3C). Taken together, our
results critically link anxiety with NAc mitochondrial function within
the neuronal synaptic compartment (Fig. 3 I–J).
Manipulating Mitochondrial Function in the NAc Affects Social
Dominance. Next, we inquired whether mitochondrial function
in the NAc could per se be causally implicated in the outcome of
a social hierarchy following a dyadic encounter. Given that both
complex I- and complex II-dependent respiration were found to
be associated with the anxiety phenotype (Fig. 3), we micro-
infused specific pharmacological inhibitors for each of these
complexes [for complex I: rotenone (ROT); for complex II: the
competitive inhibitor malonic acid (MA) and the noncompetitive
3-nitroproprionic acid (3NP)] into the NAc of separate groups of
naïve animals that were paired to another anxiety-matched male
infused with the corresponding vehicle. Microinfusion of either
ROT, MA, or 3NP reduced the success of treated animals to win
the social contest (Fig. 4A). Importantly, these treatments did
not induce side effects on social investigation or auto-grooming
during social competition (SI Appendix, Table S3), or alter lo-
comotor activity (Fig. 4B), anxiety, or sociability (SI Appendix,
Fig. S7 A–D) in additional experiments. Furthermore, these in-
hibitor treatments did not produce neurotoxic effects, as the
drugs were infused at low doses and we confirmed the absence of
lesion and neuronal death (SI Appendix, Fig. S8). The effects of
complex I or complex II inhibition on social competition were
specific for the NAc, as infusions of the same inhibitors into the
BLA had no effect on social dominance and did not affect
general locomotor activity (Fig. 4 C and D). We further showed
Fig. 2. D1-containing cells are activated by social competition. (A and B)
cFOS activation of substance P (SubP; D1-containing cells), enkephalin (ENK;
D2-containing cells), S100, and vesicular acetylcholine transporter (VAChT) in
the NAc after social competition (SC) was compared with basal levels (B) and
only substance P+ cells displayed cFOS activation in response to social com-
petition. (C) cFOS activation in substance P+ cells significantly correlated with
the duration of competitive offensive behavior. cFOS activation is presented
as percentage of basal cFOS activation induced by social competition (n = 6
pairs per group) as mean ± SEM (*P < 0.05).
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that, unlike infusion of muscimol in the BLA (SI Appendix,
Fig. S2) that interferes with BLA-dependent auditory fear con-
ditioning, microinfusion of 3NP did not affect conditioning in
this task (SI Appendix, Fig. S2), discarding that neuronal in-
activation could be a general mechanism whereby impairing
mitochondrial function would affect putative functions from the
affected brain region. Altogether, these data strongly support a
key role for complex I- and II-dependent mitochondrial function
within the NAc in the establishment of social dominance.
We then investigated whether we could reverse the disad-
vantage exhibited by high-anxious animals in the acquisition
of social dominance by boosting NAc mitochondrial function.
Nicotinamide adenine dinucleotide (NAD+) is a metabolic co-
factor present in cells that has been implicated in a wide range of
critical metabolic activities (28). Treatment with the NAD+
precursor nicotinamide (NAM; ref. 28), an amide form of vita-
min B3 that boosts mitochondrial respiration (29), into the NAc
of high-anxious rats at a time point before the social encounter
and at a dose that increased accumbal mitochondrial respira-
tion (Fig. 5A), abolished the disadvantage of high-anxious animals
to become dominant against low-anxious animals (Fig. 5B). Note-
worthy, anxiety, sociability, social investigation and auto-grooming
remained unaffected by NAM-treatment (SI Appendix, Fig. S7 E and
F and Table S3). Finally, given the higher levels of the common ROS
product 4HNE observed in high-anxious rats, we investigated whether
treating these animals with the antioxidant Mitoquinone mesylate
(mitoQ; ref. 30) in the NAc might enhance their dominance. Infusion
of MitoQ at a time (3 h before testing) and dose (10 μM) that de-
creases accumbal 4HNE levels (Fig. 5C) had no effect on reversing
the disadvantage of high-anxious rats when competing with vehicle-
infused low-anxious rats (Fig. 5D). These observations suggest that
the impact of mitochondrial function in social competition described
here is not mediated by oxidative stress but is related to mitochondrial
respiratory capacity. Taken together, our results point to a causal link
between NAc mitochondrial function and social rank.
Discussion
In this study, we show that animals’ anxiety trait is predictive of
the outcome of a competitive social encounter and reveal critical
neurobiological mechanisms underlying individual differences in
the predisposition to win or lose a social competition. Our findings
establish a key role for mitochondrial function in the NAc in the
attainment of social dominance. Althoughmitochondrial involvement
has been demonstrated in different mental health conditions, in-
cluding anxiety disorders, stress and depression (10–12, 31, 32), our
findings go beyond and establish a role for mitochondrial function in
the regulation of individual differences in social behaviors under
normal, nonpathological conditions.
First, following evidence in humans linking interindividual dif-
ferences in anxiety with social status (7) and competitive self-con-
fidence under stress (8), we showed that high-anxious rats tend to
become subordinate when confronted with low-anxious rats. Im-
portantly, the anxiety phenotype was reliably established through
two validated tests for anxiety in rodents, and the pervasive impact
of anxiety on social competition was confirmed through repeated
social encounters (Fig. 1G). As the competing rats were matched
for age, size, gender, and social experience, our findings suggested a
role for intrinsic differences in neural mechanisms involved in social
competition between high- and low-anxious individuals.
In our search for key brain regions involved in social hierarchy
establishment, we obtained evidence for the involvement of the
Fig. 4. Inhibition of mitochondrial complexes I and II in nucleus accumbens
(NAc) decreased social dominance. Intra-NAc infusion of rotenone (ROT, n =
12 pairs), 3-nitropropionic acid (3-NP, n = 10 pairs), or malonic acid (MA, n =
12 pairs) reduced social dominance (A), without affecting locomotion in the
Open Field, n = 5–6 per group (B). Intra-BLA infusions of ROT, 3-NP, or MA
had no effect on social dominance, n = 6, 9, or 10 pairs, respectively (C), or
locomotion, n = 5 per group (D). Data are mean ± SEM (**P < 0.01, ***P <
0.001, Student’s t test or one-sample t test against chance level).
Fig. 3. High-anxious rats (HA) exhibit lower mitochondrial function that is specific to the nucleus accumbens (NAc). HA exhibit lower expression of complex I
and II protein levels in the NAc than low-anxious rats (LA), n = 5–12 per group (A), but no significant difference in mitochondrial number, n = 9 per group (B).
(C) HA display lower mitochondrial respiration in the NAc than LA, n = 6 per group. (D) These differences were also detected two months following anxiety
characterization, n = 8 per group. (E) Mitochondrial respiration in the basolateral amygdala (BLA) does not differ between groups, n = 11 per group. ATP-
levels in the NAc are lower in HA than LA, n = 9–10 per group (F), whereas ROS products are higher in HA, n = 5–6 per group (G). Synaptoneurosomes were
separated from glia (H), and then mitochondrial respiration was measured in three independent experiments. The mitochondrial respiration deficit of HA is
present in synaptoneurosomes (I) but not in glia-enriched fractions (J). Data are mean ± SEM. Respiration data are presented as estimated marginal means ±
SEM of oxygen flux per mg tissue (*P < 0.05; **P < 0.01, Linear Mixed Model).
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NAc. First, we found a prominent activation of the NAc, particularly
D1-containing cells, by social competition as highlighted through the
assessment of the immediate early genes zif-268 and cFOS. Then,
pharmacological inactivation of the NAc indicated the causal in-
volvement of this brain region in social dominance. These findings
are in line with previous evidence from lesion (33), neurochemical
(34), and pharmacological (35) studies in rodents that highlight a
causal involvement of the NAc in the development and/or ex-
pression of social dominance, as well as with data from human
neuroimaging studies that show NAc activation under tasks in-
volving social competition (21) or manipulation of social status
(19, 20). Moreover, our findings are in agreement with current
views that construe a critical role of the NAc in social operations,
ranging from the processing of social information, to learning
about conspecifics and making socially influenced decisions (36).
Additionally, the NAc has been classically implicated in differ-
ent aspects of behavioral activation, including motivation, exertion
of effort during instrumental behavior, reward-seeking and energy
expenditure, as well as “vigor” of behavior (37–41). The NAc in-
volvement seems to be particularly critical when there is ambiguity
and/or uncertainty about which are the appropriate actions to be
taken or under situations of instability and fluidity (42). Neural
computations underlying these processes are all conceivably rele-
vant for the evolving interactions entailed in the establishment of a
social hierarchy. Importantly, a priori differences in motivation to
win the social context cannot explain the outcome of the social
competition between high- and low-anxious rats, as no differences
in competitive behavior were observed during the early stages of
the contest (Fig. 1H). Instead, the divergent ranks emerged pro-
gressively throughout the competition, indicating the potential for
differential underlying metabolic capacity in the NAc.
Specifically, the key role for bioenergetics in the NAc in the
differential predisposition of high- and low-anxious animals to
win a social competition was identified by a number of con-
verging data. Initial evidence in support of this concept was
found in the microarray data indicating enrichment for metabolic
and mitochondrial genes among those differentially expressed in
the NAc between high- and low-anxious rats. Subsequently, data
demonstrating lower complex I and II protein levels, mitochon-
drial respiration and ATP, but higher ROS products in the NAc
of high anxious rats in comparison with low anxious counterparts
further supported a link between variation in NAc bioenergetics
and the attained social rank. The reduction in mitochondrial
function was not simply a result of reduced mitochondrial
number, as both high- and low-anxious rats exhibited similar
mitochondrial number and densities in the NAc. Importantly,
when we pharmacologically manipulated NAc mitochondrial
respiration, we could directly influence social rank, which
strongly supports the causal implication of differential anxiety-
related NAc bioenergetics in the emergence of a dominance
hierarchy. Inhibition of either complex I or complex II in the
NAc markedly reduced social rank, whereas the competitive
disadvantage of high-anxious animals to achieve a dominant rank
against a low anxious male could be overcome by intra-NAc
infusion of the mitochondrial booster vitamin B3 (NAM). Con-
trol experiments excluded that the observed differences in social
dominance between animals differing in anxiety and those im-
pinged by the pharmacological treatments were not due to broad
alterations in social behavior or confounded by perturbations in
locomotion or general behavior. Nutritional interventions, such
as vitamin B3, have previously been proposed as therapeutics for
depression and age-related neurodegenerative diseases (43, 44).
Our results attribute a previously unidentified role for vitamin B3
as a potential target to deal with anxiety-related deficits in
competitiveness. However, pharmacological administration of
the mitochondrial antioxidant MitoQ was ineffective to reverse
the competitive disadvantage of high-anxious animals. Although
these data are not supportive for a role of ROS in the subordinate
outcome of high-anxious rats, we cannot discard the effective-
ness of other antioxidant administration regimes (i.e., other ad-
ministration timing, doses, and/or chronicity). Interestingly,
although there is increasing evidence linking differences in mi-
tochondrial function and oxidative stress with clinical patholo-
gies such as anxiety disorders (31, 45–47), here we go beyond the
pathological state and show that differences in brain mitochon-
drial function in the NAc can be found in association with
personality differences.
In our study, several control experiments targeting the BLA
suggested that the observed bioenergetic effects on social compe-
tition are specific to the NAc. Although these findings might seem
surprising given the classical view of the BLA as a regulatory center
for anxiety, anxiety modulation by the BLA has now been dem-
onstrated to take place at its outputs, rather than within the BLA
itself (reviewed in ref. 48). Given the proposed roles of the NAc in
the regulation of behavioral vigor and exertion of effort, particu-
larly in appetitively or aversely motivated behaviors (42), it is now
tempting to speculate that the detected differences in mitochon-
drial function in the NAc as a function of anxiety could be critically
involved in the decision-making processes weighing the amount of
effort and/or cost exerted against the tradeoff of the prospect to
win or, more generally, in defining differences in vulnerability to
persist during sustained challenge.
The fact that suboptimal mitochondrial function in high-anxious
rats was found in the NAc and not the BLA, suggests that the
differences in the NAc could be secondary in this brain region and
not a generalized mitochondrial dysfunction. Among the possible
mechanisms involved, it is tempting to consider the participation
of the dopaminergic system as several studies have linked high
dopamine levels with reduced mitochondrial capacity in cells (49,
50). As we found activation of D1-containing cells following social
competition, it is possible that differences in dopamine, as a
function of anxiety, could contribute to the observed differences in
mitochondrial function.
Substantial evidence implicates the NAc in depression (51, 52)
and “anergia,” or lack of energy at the core of depression and
anxiety disorders (53, 54). Furthermore, mitochondrial deficiency is
frequently observed in brain disorders (55), including depression
(13, 14, 26, 31, 56) and anxiety (9). Moreover, individuals with
mitochondrial disorders often express symptoms of depression and
anxiety (10–13). High anxiety trait is a known vulnerability factor to
develop depression, particularly if individuals are exposed to stress
(57, 58), with stress impinging energetically costly neuronal adap-
tations (59, 60). Limited energy production due to reduced mito-
chondrial function may impair adaptive neuronal capacity to life
Fig. 5. Enhancing nucleus accumbens (NAc) energy stores via nicotinamide
(NAM) infusion abolished the competitive disadvantage in high-anxious (HA)
animals. (A) Intra-NAc infusion of NAM before social competition increased
mitochondrial respiration in HA rats, n = 7 per group. (B) NAM-treated HA
rats had similar chances to become dominant as low-anxious (LA) rats, n =
9–11 pairs. Intra-NAc infusion of mitoquinone mesylate (mitoQ) reduced local
ROS products (C), n = 5, but did not enhance social competition in HA rats
(D), n = 8 pairs. Data are presented as mean ± SEM (*P < 0.05, ***P < 0.001,
one sample t test against baseline or chance level).
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challenges (32) and contribute to the development of psycho-
pathologies (9, 10, 13, 14). Therefore, our results highlight dif-
ferences in mitochondrial function in the NAc as a potential
mechanism underlying the susceptibility or resilience to develop
depression, and may open new prospects for the advancement of
preventive therapeutic approaches to mood disorders.
Materials and Methods
Adult male Wistar rats (Charles River) weighing 250–275 g at the start of ex-
periments were used. All experiments were performed with the approval of
the Cantonal Veterinary Authorities (Vaud, Switzerland) and carried out in
accordance with the European Communities Council Directive of 24
November 1986 (86/609EEC). Detailed descriptions of animal housing con-
ditions, statistical analyses, and experimental methods are provided in the
SI Appendix, SI Materials and Methods.
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Materials and Methods:  
Animals. Adult male wistar rats were used for all experiments. Animals were 
individually housed in polypropylene cages (57 x 35 x 20 cm) with abundant pine 
bedding in a temperature- (23C) and light- (0700-1900 h) controlled room. All animals 
had ad libitum access to standard food and water. Upon arrival to the facility, animals 
were allowed to habituate to the vivarium for one week and were then handled for 2 
min/d during 3 days prior to the start of all experiments. All behavioral manipulations 
were performed during the light phase by experimenters blind to treatment groups. 
Unless otherwise indicated, all animals were first characterized for trait anxiety and 
then sacrificed under basal conditions for ex-vivo analyses. All efforts were made to 
minimize the number of animals while maintaining statistical rigor.  
 
Statistical analyses. All samples represent biological replicates. Sample sizes are 
indicated in the figure legends. Unpaired two-tailed Student’s t-tests were used to 
compare sets of data obtained from independent groups of animals. In follow-up 
experiments, unpaired one-tailed Student’s t-tests were used to confirm previous 
findings. Within-pair amounts of behavior in the social competition test were compared 
using paired two-tailed Student’s t-tests. In sets of data in which animals were matched 
for anxiety, relative social dominance scores were compared using one-sample t-tests 
against chance (50%). When necessary, data were transformed to obtain symmetric 
distributions for statistical analysis. Figures are presented with original, non-
transformed data. All data –except for mitochondrial respiration- were analyzed using 
Prism version 5.01 (Graphpad software Inc., San Diego, CA). For respiration 
experiments, data were analyzed using SPSS statistical software version 13.0 (SPSS, 
Chicago, IL). As experiments were performed in blocks across days, a linear mixed 
model was created that included block as a random effect in addition to fixed effects 
of either anxiety or treatment (where appropriate). The estimated marginal means of 
the model are then reported. P-values are reported in figure legends, with the second 
decimal rounded to the nearest figure. Statistical significance was considered at the 
p<0.05 level. 
 
Elevated Plus Maze. Prior to the testing for social hierarchy, animals were tested for 
anxiety-related behavior in the EPM as previously described (1). Lighting was 
maintained at 15-16 lx on the open arms and 5-7 lx in the closed. Depending on the 
amount of time spent on the open arm animals were classified as high- (HA, ≤5% open 
arm duration) intermediate (IA, 6-20 % open arm duration) or low-anxious (LA, ≥20% 
open arm duration). Before and in between testing the apparatus was cleaned with a 
5 % EtOH solution. 
 Light-Dark box. To ascertain that the anxiety-like behavior measured in the EPM is 
indeed a reliable indicator for anxiety; animals were also tested in the light-dark box, 
2 d after EPM-exposure. The apparatus and procedure are the same as that described 
in a previous publication (1), with the modification of lighting intensity. One chamber 
was black (dark box) and kept at 20lx while the other chamber was white (light box) 
with an illumination level of 160lx. Before and in between testing the apparatus was 
cleaned with a 5% EtOH solution.  
 
Social hierarchy test. Rats were pair-wise matched for weight but, depending on the 
purpose of the experiment, animals in each pair were either of a similar or opposite 
anxiety profile. In experiments that aimed at disentangling the impact of anxiety in the 
formation of a social hierarchy, rat pairs were composed of a high- and a low-anxious 
rat. In pharmacological experiments addressed to investigate the impact of specific 
treatments on social dominance, pairs of animals were matched for similar anxiety 
levels; i.e., the rats in each dyad were considered equal in their probability (= 50%) to 
become dominant or subordinate during their encounter. 
As previously described (2), animals were marked on their body for 
identification and placed in pairs in a clean (neutral) cage without food or water for 20 
min. During the social hierarchy test both rats displayed spontaneously offensive 
behavior, but this balance typically shifted in the favor of one animal towards the end 
of the test. Social dominance was estimated by summation of the total duration of 
offensive behaviors for each rat in the dyad (offensive upright, lateral threat and 
keeping-down behavior, as previously described (3)). Earlier we found that social 
dominance in these encounters correlate with the outcome in competition for water or 
for food rewards (1). During pilot studies, we found that infrequently offensive behavior 
was virtually absent during social encounter (no rat displaying >10s of total offensive 
behavior); these pairs were excluded from analysis as the relative social dominance 
in these pairs cannot be reliably measured. Auto-grooming and social investigation 
was taken into account to determine the specificity of the drug-effects on offensive 
behavior.  
 
Social preference test. The social preference test was performed in a rectangular, 
three-chambered box that included a central compartment where the rat was initially 
placed. Thereafter, retractable doors were removed and the rat could explore the left- 
and right-compartment for 5 min. The left- and right-compartments were equipped with 
a floor-fixed transparent perforated Plexiglas cylinder that contained either an 
unfamiliar male juvenile rat or an unfamiliar object. The time spent sniffing either the 
juvenile (social target) or the novel object (inanimate target) was manually scored from 
videotapes by an experimenter who was blinded to the treatment groups.  
 
Open Field test. The open field was used to determine the effects of intra-NAc and 
intra-BLA infusion of the mitochondrial complex I-and II inhibitors rotenone, 3-
nitroproprionic acid, and malonic acid on locomotor behavior. The open field apparatus 
and procedure were previously described (1). The light was adjusted to a level of 8-10 
lx in the center of the arena.  
 In situ hybridization. Rats were characterized for anxiety and sacrificed either under 
basal conditions or 5 min after a paired social competitive encounter. Brains were 
rapidly dissected out, frozen at -30C in isopentane and stored at -80C until further 
processing. 20m sections were obtained on a freezing cryostat and prepared and 
hybridized as previously described (4). An outline was created for each region of 
interest from the left and right sides of the brain from rostral/caudal sections. The 
radioactive signal was quantified from 8-12 brain sections per region per rat using 
MCID Image Analysis software (MCID, UK). Optical density values were background-
corrected, multiplied by the area sampled to produce an integrated density 
measurement, and then averaged to produce one data point for each brain region for 
each animal for statistical analysis.   
 
Corticosterone Analysis. Rats were characterized for anxiety and sacrificed either 
in basal conditions or 5 min after a paired social competitive encounter. Trunk blood 
was collected and centrifuged at 12,000 rpm to isolate plasma. 10L of plasma sample 
were then prepared according to manufacturer’s instructions to measure 
corticosterone concentrations using a corticosterone ELISA kit (Enzo Life Sciences, 
ADI-901-097). Levels were calculated using a standard curve method. 
 
Intracerebral cannulation surgery. Rats subjected to pharmacological experiments 
were implanted bilateral with stainless steel guide cannulas aimed at the NAc or BLA. 
Rats were anesthetized by isoflurane inhalation (induction 4% isoflurane for 4 min and 
maintenance 2.5% isoflurane in O2 at a flow of 4L/min) and placed in a stereotaxic 
apparatus (David Kopf Instruments, Tujunga, CA, USA). Small holes were drilled 
through the skull for bilateral placement of stainless steel 22 gauge guide cannulae 
(Plastics One, Roanoke, VA, USA) fitted with a removable dummy cannula. 
Coordinates were based on the atlas of Paxinos and Watson (5) and are taken from 
bregma (in mm) for NAc: A.P. +1.2, M.L. ±1.5, D.V. -6.50 and for BLA: A.P. -2.80, ± 
4.90, D.V. -7.50. Cannulae were fixed to the skull with two anchoring screws and 
dental acrylic (Duralay 2244; Reliance, Worth, IL). After behavioral experiments 
animals were sacrificed by i.p. pentobarbital injection and correct cannulae 
placements was routinely verified with Evans blue histology.  
 
Drug infusions. Behavioral experiments involving mitochondrial complex inhibitors 
were performed 10 min after drug administration. Behavioral experiments involving 
pharmacological inactivation were performed 30 min after drug administration. We 
randomly assigned animals to their respective treatment. For intra-cerebral infusions 
the dummy was removed and an injector was inserted that extended 1- (BLA) or 2mm 
(NAc) from the tip of the cannulae. All drugs were bilaterally infused in a total volume 
of 0.3 L during 1 min of constant flow. The injector remained in place for one 
additional minute after infusion to allow proper diffusion. 0.224nM rotenone (complex 
I-inhibitor, Sigma-Aldrich) was dissolved in DMSO. 0.849nM Malonic Acid and 
0.742nM 3-nitroproprionic acid (complex II-inhibitors, Sigma-Aldrich) were dissolved 
in saline. Muscimol (Tocris Biosciences, Bristol, UK) was dissolved in saline. All 
inhibitors were infused at a dose of 25ng. Mitoquinone mesylate (mitoQ) was dissolved 
in saline with 10% DMSO and bilaterally infused (0.5 μL) at a concentration of 10μM 
3 h prior to social competition or brain sampling for the assessment of 4HNE. 57.8 nM 
nicotinamide (NAM, Sigma-Aldrich) was dissolved in saline and bilaterally infused at 
a dose of 2g 3 h prior to social competition or respirometry. No animal received a 
repeated ETC drug infusion. 
 
Auditory Fear Conditioning. Naïve rats received intra-BLA infusions of saline, 3-
nitroproprionic acid, or muscimol prior to the training session of auditory fear 
conditioning. Animals were tested for acquisition of the fear memory by exposure to 
the auditory stimulus one week after training. Training and testing took place in a 
rodent fear conditioning cage (30×37×25 cm) placed into a sound-attenuating 
chamber. The side walls of the fear conditioning cage were constructed of white 
metacrylate, while the door and the top cover were Plexiglas. The floor consisted of 
20 steel rods through which a scrambled shock from a shock generator could be 
delivered (Panlab, S.L., Barcelona, Spain). Following drug infusions, the animals were 
placed in the conditioning chambers. During the training session, rats were exposed 
to one context (consisting of white rectangular walls, a steel grid floor, white lights, that 
was cleaned with 5% ethanol before each trial) for a duration of 160s, followed by 
three presentations of tone-shock pairings in which the tone (20s, 80dB, 800Hz) co-
terminated with a foot shock (0.6mA, 1s). The intertone interval was 40s. One week 
after the training session, the animals underwent a test session in a novel context 
(metallic grid walls, a gray plastic floor, green lights, that was cleaned with 1% acetic 
acid before each trial) for 8 min where the same training tone was presented during 
the last 5 min. Acquisition of fear was quantified as the amount of time the rats spent 
freezing during the testing session. Freezing was defined as the lack of all movement 
(except for respiratory-related movements). 
 
Triple labeling Immunofluorescence. Preparation. Rats were anaesthetized with a 
lethal dose of pentobarbital and sacrificed by transcardial perfusion using 0.9% saline 
solution followed by a fixative solution of paraformaldehyde 4% in PBS (pH=7.5). The 
brains were removed, post-fixed for 4 h in 4% paraformaldehyde/PBS and 
cryoprotected in 30% sucrose/PBS. Coronal sections (30 μm thick) were cut on a 
cryostat (Leica, CM3050 S), and free-floating sections were triple labeled for cFOS, 
DAPI, and one of four antibodies against the main cell-types of the NAc.  The floating 
sections were rinsed briefly with PBS then blocked 1 h in PBS - 0.1% Triton X-100 
(Sigma-Aldrich) - 5% normal donkey serum (Jackson ImmunoResearch) and 
incubated overnight at 4 °C with rabbit anti-cFOS (Milllipore, ABE457, 1:500) and one 
of the following: goat anti-Substance P (for staining of D1-containing cells, Santa Cruz, 
sc-9758, 1:100), mouse anti-S-100 (for staining of astrocytes, Abcam, ab4066, 1:100), 
or goat anti-vesicular acetylcholine transporter (VAChT, for staining of cholinergic 
cells, Millipore, ABN100, 1:2,000). Rabbit anti-Met Enkephalin (for staining of D2-
containing cells, Abcam, ab22620, 1:1,000) was incubated with goat anti-cFOS (Santa 
Cruz, sc-52-G, 1:50). Both cFOS antibodies were confirmed as exhibiting similar 
staining in a cFOS/cFOS double labeled control experiment. The sections were 
washed in PBS and incubated for 2 h at room temperature with the secondary 
antibodies: donkey-anti-rabbit IgG Alexa 568 conjugate (Lifetechnologies, A10042, 
1:1,000), donkey anti-goat IgG Alexa 488 conjugate (Lifetechnologies, A11055, 1:800) 
or goat anti-mouse IgG Alexa Fluor 488 conjugate (Lifetechnologies, A11029, 1:800). 
After washing in PBS the sections were incubated 10 minutes in DAPI (Sigma, 
1:10,000), rinsed and mounted with Fluoromount-G (SouthernBiotech). Images were 
captured with a confocal microscope (Zeiss, LSM700) using a × 20 objective. The 
sample images were captured at the same coordinates for each animal. A mosaic of 
16 images were captured and stitched together for one hemisphere. For visualization 
purposes, representative regions within specific sections were zoomed and enhanced 
in a linear manner for brightness and contrast using FIJI software. Enhanced images 
were then arranged within photoshop CS (Adobe). Quantification was performed on 
original, unenhanced images only.  
Quantification of immunofluorescence LSM images were stitched together using the 
grid stitching plug-in for FIJI (6). The backgrounds of each channel were measured at 
five different random areas around the section and averaged together to generate a 
mean background for each channel. This mean background was then subtracted from 
each channel. Cells were delineated using a Huang threshold to label only those 
stained with DAPI within 20-200 pixels. The number of these cells that were also 
labeled with cFOS and the antibody of interest were counted and converted to a 
percentage of the total number of DAPI-stained cells for each section. Sections were 
then averaged to provide one value per animal per cell-type of interest.  
 
Microarray. Naïve rats were characterized for trait anxiety on the elevated plus maze 
(high-, intermediate-, and low- anxious rats, n=5/group) and were sacrificed under 
basal conditions by rapid decapitation. Brains were flash frozen and NAc were tissue-
punched on a freezing cryostat with a 2.0mm tissue punch (Harris UniCore, USA). 
RNA was extracted using Ambion RNaqueous-micro kit (Life Technologies) which 
were then converted to cDNA libraries using Nugen Ovation Pico WTA system v2 
reaction kits (Nugen, USA). cDNA was fragmented and labeled using the Encore Biotin 
Module (Nugen, USA) and hybridized to Affymetrix 1.0 Exon ST arrays (Affymetrix). 
The arrays were scanned to produce raw signal intensity values for all probes. These 
values were then preprocessed using the Robust Multichip Average algorithm (RMA; 
(7). Gene expression was analyzed using the limma package (8) within Bioconductor 
(9) in order to generate a model that treated anxiety as a linear predictor and produce 
a rank-ordered list of p-values. This rank-ordered list was then used to perform gene 
enrichment analysis using the GSEA software (10). We first searched for significantly 
associated gene sets within the C5 subclass (GO gene sets), taking a cutoff of a 
nominal p-value of 0.10. As the top biological processes that were differentially 
regulated between anxiety phenotypes were metabolic, we then examined our data 
for enrichment of mitochondrial genes using a custom curated gene set.  
 
Western Blots. Rats were sacrificed under basal conditions by rapid decapitation and 
the nucleus accumbens was tissue-punched on a freezing cryostat with a 2.0 mm 
tissue punch (Harris UniCore). Briefly, tissue was homogenized in ten volumes of ice-
cold sucrose (0.32 M) and HEPES (5 mM) buffer that contained a cocktail of protease 
inhibitors (Complete TM, Roche, UK) with 16 strokes and centrifuged at 1, 000 x g for 
5 min. The resulting total fraction pellet was resuspended in Krebs buffer with 1% NP-
40, incubated at 4C for 40 min, and then centrifuged at 10,000 x g for 20 min at 4C. 
Protein concentration for each sample was estimated by BCA protein analysis (Bio-
Rad). 15g of protein were loaded in each well and then separated on 10% (w ⁄ v) 
SDS-PAGE and transferred (70V, 1.5 h) to a nitrocellulose membrane (Whatman). 
Multiple gels were loaded in a counterbalanced manner and run simultaneously for 
two separate experiments. After saturation of the nonspecific sites with 5% (w ⁄ v) skim 
milk in PBST, the blots were incubated overnight at 4C with primary antibodies against 
the mitochondrial complexes I-V (MitoProfile Total OXPHOS Rodent WB Antibody 
cocktail, MitoSciences, cat No. MS604). Polyclonal mouse anti-rat antibodies for Actin 
(1:30,000; Life Technologies, cat. No.9485) were incubated as loading controls. The 
blots were washed with PBST, incubated for 1 h with a secondary antibody, an anti-
rabbit (anti-mouse for loading controls) Ig peroxidase conjugate (whole molecule 
conjugate; diluted 1:10,000; Sigma) and finally developed using an enhanced 
chemiluminescence (ECL) system (Pierce). For the quantification, bands were 
revealed with a ChemiDoc imaging system (Bio-Rad) for optimum exposure time. 
Images were then analysed using QuantityOne software v4.6.3 (Bio-Rad) where the 
adjusted volume was calculated and recorded for each band. For each group, adjusted 
values were normalized to Actin. 
 
Mitochondrial Copy Number. Rats were sacrificed under basal conditions by rapid 
decapitation and the nucleus accumbens was rapidly dissected out, frozen at -30C in 
isopentane, and stored at -80C until further processing. Tissue was placed in lysis 
buffer and DNA was extracted using DNeasy extraction kit (Qiagen). DNA 
concentrations were measured using the Nanodrop. Oligonucleotide primers for real-
time quantitative PCR and tested to ensure all efficiencies were above 95%. All 
primers were efficient between 97.8 and 99.7%. Primers tested includ: ND1, fwd 
TCCTCTTATCCGTCCTCCTAATAA; rev CAGGCGGGGATTAATAGTCA; GAPDH, 
fwd AAACCCATCACCATCTTCCA; rv CCTCGAAGTACCCTGTGCAT. Each reaction 
contained 200 nM each of the forward and reverse primers, SYBR Green PCR Master 
Mix (Applied Biosystems) and 10 ng sample DNA in a 20 µl reaction volume. The 
qPCR reactions were performed in triplicates in an ABI Prism 7900 Sequence 
Detection System (Applied Biosystems). The standard cycling conditions were 95°C 
for 5 min, followed by 40 cycles of 95°C for 30 s, and 60°C for 30 s. Melt curves were 
generated at the end of the regular qPCR cycles.The comparative Ct method was 
used to determine raw copy number. MtDNA levels were normalized to the nuclear-
encoded gene, GAPDH.  
 
Electron Microscopy. Preparation. Rats were anaesthetized with a lethal dose of 
pentobarbital and then sacrificed under basal conditions by transcardial perfusion of 
2.5% glutaraldehyde and 2% paraformaldehyde in 0.1M PB (pH7.4). The brains 
removed 2h after perfusion. Sections (80 µm) were cut in the coronal plane at the level 
of the NAc. Sections where washed in cacodylate buffer (0.1M, pH 7.4) and postfixed 
in 1% osmium tetroxide/1.5% potassium ferrocyanide, 1% osmium tetroxide, and 1% 
uranyl acetate, each fixation step lasting 40 min. The sections were dehydrated in 
increasing ethanol concentrations, before being washed in propylene oxide, and 
infiltrated with Epon resin. Sections where then flat embedded between two glass 
slides coated in mold releasing agent (Hobby time, Glorex, Switzerland) and 
polymerized at 60°C for 24h. Sections (50nm) where then cut through the NAc using 
a diamond knife and collected onto copper slot grids with a pioloform support film. 
Imaging. Sections were imaged with a transmission electron microscope (Tecnai 
Spirit, FEI company, Eindhoven, The Netherlands) at 80 KeV and a magnification of 
2.29nm x 2.29nm per pixel and images captured with a CCD camera (4k x 4k Eagle 
camera, FEI company).  
Quantification. Mitochondrial density and size were measured blind using the TrakEM2 
software in Fiji (11). A counting square, with an area of 66.9 μm2, was drawn on each 
image. Mitochondria inside this square, as well as those touching the top and right 
edges (inclusion lines), were counted. Those touching the bottom and left were 
excluded (exclusion lines). The largest diameter was measured, and mitochondria 
were also classified as to whether they were seen in dendrites, or elsewhere. A total 
of 377 counting squares were analyzed from 6 animals (n = 3/group for high- and low-
anxious rats). 
 
Mitochondria Respirometry. Animals were characterized for anxiety and sacrificed 
under basal conditions by rapid decapitation and the nucleus accumbens and 
basolateral amygdala were rapidly dissected out, weighed, and placed in a petri dish 
on ice with 2 mL of relaxing solution (2.8 mM Ca2K2EGTA, 7.2 mM K2EGTA, 5.8 mM 
ATP, 6.6 mM MgCl2, 20 mM taurine, 15 mM sodium phosphocreatine, 20 mM 
imidazole, 0.5 mM dithiothreitol and 50 mM MES, pH = 7.1) until further processing. 
Tissue samples were then gently homogenized in ice-cold respirometry medium 
(MiR05: 0.5 mM EGTA, 3mM MgCl2, 60 mM potassium lactobionate, 20 mM taurine, 
10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose and 0.1% (w/v) BSA, pH=7.1) with 
an eppendorf pestle. Then, 2 mg of tissue were used to measure mitochondrial 
respiration rates at 37°C using high resolution respirometry (Oroboros Oxygraph 2K, 
Oroboros Instruments, Innsbruck ,Austria),  as previously described for other tissues 
(12). A multisubstrate protocol was used to sequentially explore the various 
components of mitochondrial respiratory capacity. To measure the respiration due to 
oxidative phosphorylation, we added substrates for the activation of specific 
complexes. Thus, oxygen flux due to complex I activity (Complex I) was quantified by 
the addition of ADP (5 mM) to a mixture of malate (2mM), pyruvate (10mM) and 
glutamate (20mM), followed by the addition of succinate (10 mM) to subsequently 
stimulate complex II (Complex I + II). We then uncoupled respiration to examine the 
maximal capacity of the electron transport system (ETS) using the protonophore, 
carbonylcyanide 4 (trifluoromethoxy) phenylhydrazone (FCCP; successive titrations of 
0.2 µM until maximal respiration rates were reached). We then examined consumption 
in the uncoupled state due solely to the activity of complex II by inhibiting complex I 
with the addition of rotenone (0.1µM; ETS CII). Finally, electron transport through 
complex III was inhibited by adding antimycin (2 µM) to obtain the level of residual 
oxygen consumption (ROX) due to oxidating side reactions outside of mitochondrial 
respiration. The O2 flux obtained in each step of the protocol was normalized by the 
wet weight of the tissue sample used for the analysis and corrected for ROX. All 
respiration experiments comprise 2-3 counterbalanced blocks across days.  
 
Quantification of ATP. Animals were characterized for anxiety and sacrificed under 
basal conditions by rapid decapitation. The NAc was dissected out and placed in 2 mL 
of relaxing solution (2.8 mM Ca2K2EGTA, 7.2 mM K2EGTA, 5.8 mM ATP, 6.6 mM 
MgCl2, 20 mM taurine, 15 mM sodium phosphocreatine, 20 mM imidazole, 0.5 mM 
dithiothreitol and 50 mM MES, pH = 7.1) until further processing. Tissue samples were 
then diluted 10x in a tricine buffer solution (40 mM Tricine, 3 mM EDTA, 85 mM NaCl, 
3.6 mM KCl, 100 mM NaF and 0.1% saponin, pH 7.4; Sigma Aldrich). ATP content 
was determined enzymatically with luciferase in a 96-well plate. In the presence of 
ATP, Mg2+ and oxygen, luciferin is oxygenated by luciferase into oxyluciferin. This 
reaction emits light which is proportional to the amount of ATP in the sample. ATP was 
measured with the CellTiter-Glo Luminescent Cell Viability Assay (Promega), with a 
few minor modifications. A converting solution (100 mM Tricine, 100 mM MgSO4, 25 
mM KCl) was added to tissue samples and allowed to incubate at room temperature 
for 5 min. After incubation, a MgCl2 solution (4 mM tricine and 100 mM MgCl2) was 
added to the samples, followed by, 100 μl of CellTiter-Glo reagent (G7571, Promega). 
Additionally, each 96-well plate contained a series of 10-fold dilutions (1µM – 10nM) 
of an ATP standard (Sigma), in order to generate a standard curve for each assay. 
Luminescence was immediately detected with a luminometer (Safire 2, Tecan). 
Luminescence was measured kinetically via 30 samples taken at 1 min intervals. At 
least 4 points at the plateau were taken to generate an average maximum 
luminescence for each sample. ATP was calculated using the standard curve to 
determine the concentration of ATP.  
 
Quantification of lipid peroxidation product 4-HNE. Animals were characterized for 
anxiety and either sacrificed under basal conditions by rapid decapitation or infused 
with 10µM mitoQ in the NAc and sacrificed 3 h afterwards. The brain was extracted, 
frozen at -30°C in isopentane and stored at -80°C until further processing. In basal 
samples, NAc punches were obtained using on a freezing cryostat and then processed 
for 4-HNE accumulation using a 4-HNE ELISA assay (Cell BioLabs, Cat.No. STA-334 
and STA-838) according to manufacturer’s instructions. Samples receiving mitoQ 
were rapidly fresh-dissected for the NAc and then processed for 4-HNE accumulation 
as described above.  
 
Isolation of synaptoneurosomal- and glial-enriched fractions. To separate 
synaptoneurosomes from glial cells, we followed procedures for separation via percoll 
gradient detailed in (13). Briefly, rats were sacrificed under basal conditions by rapid 
decapitation and nucleus accumbens from 3 animals per group per experiment were 
pooled together, rapidly dissected out, and immediately homogenized in a glass tissue 
grinder in homogenization buffer (1.28M sucrose, 4mM EDTA, 20mM Tris, 50mM DTT, 
pH 7.4) by 10 even strokes. The homogenate was centrifuged at 1,000g for 10 min at 
4°C. The supernatant was collected and carefully loaded onto a prepared percoll 
gradient column (consisting of layers 3, 10, 15, and 23% percoll) and then centrifuged 
at 31,000g for 5 min. at speed at 4°C. Individual synaptoneurosomal- and glial-
enriched fractions were then carefully collected from each corresponding percoll layer 
and protein concentration was determined using the Bradford assay. Both fractions 
were then washed with ice-cold sucrose/EDTA buffer and centrifuged at 15,000g for 
15 min. As these two fractions were separated for their subsequent inclusion in 
respiration analyses, the obtained pellets were resuspended in Mir05 solution and 
immediately placed inside the Oroboros chambers for respirometry measurements. 
Five µg of each fraction were reserved and directly loaded onto a 12.5% (w/v) SDS-
PAGE for western blot analysis against mouse anti-NeuN (a neuronal marker; Millipore 
MAB377, 1:1,000), mouse anti-S100 (astrocytic marker; Abcam, ab4066, 1:100), and 
mouse anti-GAPDH (loading control, Abcam, ab8245, 1:30,000) in order to ensure 
successful cell separation (see methods Western Blots).  
 
Histology. Animals were bilaterally implanted with cannulae aimed at the NAc, as 
described above. They received one unilateral infusion (25 ng/ 0.3 μl) of either 
rotenone, malonic acid, or 3-nitropropionic acid (3NP), with the opposing side 
receiving the corresponding vehicle (DMSO for rotenone and saline for malonic acid 
and 3NP treatments). Animals were sacrificed at 24h by pentobarbital injection 
followed by transcardial perfusion of 0.9% saline solution and paraformaldehyde 4% 
in PBS (pH=7.5).  
H-E staining For hemotoxylin-eosin (HE) staining, brains were dehydrated using 
increasing steps of EtOH and embedded in paraffin. Sections were cut (10 μm), fixed 
in acetone for 10 min, and rinsed in distilled water. Sections were incubated with 
hemotoxylin for 5 min, gently rinsed in tap water for 10 min, and stained in eosin for 2 
min. Sections were rinsed in distilled water, dehydrated, and mounted. Images were 
captured using a brightfield slide scanner (Olympus Slide Scanner VS120-L100).  
Cleaved caspase 3 For cleaved caspase 3 analysis, brains were removed, post-fixed 
for 4 h in 4% paraformaldehyde/PBS and cryoprotected in 30% sucrose/PBS. Coronal 
sections (30 μm thick) were cut, and free-floating sections were then labeled with a 
primary antibody against cleaved-caspase 3. Briefly, the floating sections were rinsed 
with Tris-buffered saline/0.1% Triton-X-100 (TBS-T), and endogenous peroxidases 
were blocked by incubation in 0.3% H2O2/TBS-T. After washing, sections were 
blocked in 5% normal donkey serum/TBS-T and incubated overnight at 4°C with 
antibodies against rabbit anti-cleaved caspase 3 (Cell Signaling, 9661s, 1:400). The 
sections were washed in TBS-T and incubated for 1 h at room temperature with 
biotinylated goat anti-rabbit IgG  (both 1:200; Vector Laboratories). Images were 
scanned using a brightfield slide scanner at 20x magnification (Olympus Slide Scanner 
VS120-L100) and converted to tiff images using the VSI reader actionbar for ImageJ. 
Images were adsorbed, regions of interest at the site of drug infusion were drawn, and 
light intensity was measured. At least two sections from each animal were measured 
and averaged to generate one value per hemisphere per animal for each drug infusion.  
 
 
 
 Fig. S1. Characterization of high-anxious and low-anxious rats. Rats exhibiting a high- 
(HA) or low-anxiety (LA) profile based on time spent on the open arms of the elevated 
plus maze (EPM) also differed in the number of open arm entries on the EPM (A). In 
the light-dark box, high-anxious rats differed from low-anxious rats on all relevant 
parameters in the expected direction; a reduced latency to enter the lit compartment 
(B), an increased latency to enter the lit compartment (C) and reduced number of total 
dark-light transitions (D), n= 22-24/group. During social competition, HA rats displayed 
a reduced duration of behaviors associated with social dominance: offensive upright 
(E), lateral threat (F) and keeping down (G), n= 24/group. Following social competition, 
corticosterone levels were significantly increased compared to home cage controls, 
though at both time points, HA and LA rats exhibit similar corticosterone levels (H), n= 
10-20/group. Intra-NAc muscimol did not affect locomotor activity in the open field (I), 
n= 8/group. Data are presented as mean ± SEM (*p<0.05, **p<0.01; ***p<0.001, 
Student’s t-test).  
 Fig. S2. Acoustic fear conditioning is unaffected by the infusion of the complex II non-
competitive inhibitor 3-nitroproprionic acid (3NP) into the basolateral amygdala (BLA). 
Whereas, intra-BLA infusion of muscimol (Mus; n= 4) before training in the acoustic 
fear conditioning task markedly reduced freezing in response to a tone during the 
testing session, administration of 3NP (n= 8) had no effect on freezing at testing, as 
compared to saline (SAL; n= 5) controls. Data are presented as mean ± SEM 
(**p<0.01; one-way ANOVA, bonferroni post-hoc comparisons).  
  
  
Fig.S3. Representative images of enkephalin (ENK, for D2-containing cells; A), S100 
(for astrocytic cells; C), and vesicular acetylcholine transporter (VAChT, for cholinergic 
cells; E) under basal conditions and following social competition. Double-labeling with 
cFOS found that neither ENK, S100, nor VAChT correlate significantly with the amount 
of offensive behavior (B, D, F). 
 
 
 
 
 
 
  
 
Fig. S4. Gene enrichment analysis indicates a pattern of differential gene expression 
for metabolic processes and functions within the NAc between high- and low-anxious 
rats. Gene expression microarrays on high- and low-anxious rats under basal 
conditions (n= 5/group) were performed and analyzed for enrichment using Gene Set 
Enrichment Analysis (GSEA) software when examining across general GO gene sets 
(A) Enrichment analysis on a curated set of mitochondrial genes identified significantly 
enriched gene sets related to mitochondrial organization and function (B).  
 
 
B 
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 Fig. S5. Correlations between anxiety-like behavior on the elevated plus maze  and 
oxygen consumption for (A) stimulation of complex I (CI) by addition of ADP; (B) 
stimulation of complex II (CII) by addition of succinate; (C) maximal electron transport 
system capacity (ETS) by addition of FCCP; and (D) maximal capacity due only to 
complex II (ETS CII) by addition of rotenone. Coefficient of determination (r2) and p-
values calculated from linear regressions.  
 
 
 
 
 
 
 
 Fig. S6. The difference in mitochondrial respiration between high-anxious (HA) and 
low-anxious (LA) rats was not the result of differential mitochondrial vulnerability. 
When mitochondria are damaged, the addition of cytochrome c will replace what had 
leaked out and therefore enhance respiration. Here, we show that both HA and LA 
homogenates are unaffected by the addition of 10µM cytochrome c, indicating no 
differential damage upon processing (A). Data are presented as estimated marginal 
means ± SEM of oxygen flux per mg tissue using a two-way repeated-measures Linear 
Mixed Model, n=8/group. Differences in trait anxiety respiration were not related to 
differences in adult body weight (B), locomotor activity in the open field (C) or overnight 
food intake (D), n= 7-11/group.  
 
 
 
 
  
Fig. S7. No effect of mitochondrial treatment on anxiety and social preference. Intra-
NAc infusion of rotenone (ROT) had no effect on anxiety (A) or social preference (B).  
Infusion of 3-nitroproprionic acid (3NP) similarly did not affect anxiety (C) or social 
preference (D). Intra-NAc infusion of nicotinamide (NAM) also did not affect anxiety 
(E) or social preference (F), n= 9-12/group. Data are presented as mean ± SEM 
(**p<0.01, ***p<0.001, Student’s t-test or one-sample t-test against chance- level). 
 
 
 
 
 
  
 
Fig. S8. The intra-NAc infusion of malonic acid (MA) or 3-nitroproprionic acid (3NP) at 
the dosing scheme used in the current study (25ng/hemisphere, 10 min prior to 
behavioral testing) did not affect gross brain morphology as shown by HE-staining 
(A,B). Nor were there effects of the mitochondrial inhibitors on apoptotic cell death (C-
D) as evidenced by the amount of cleaved-caspase 3. Data (D) are represented as 
mean ± SEM (n= 3/group, Student’s t-test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Supplementary Table 1: Differentially expressed genes between high- and low-anxious rats from curated mitochondrial gene sets 
mRNA 
Accession # 
Gene 
Symbol Gene Description 
GO 
Accession GO name 
P-
Value 
NM_001002253  Atp6v0e2  ATPase, H+ transporting V0 subunit e2  
> 
GO:0015991 
ATP hydrolysis 
coupled proton 
transport 
0.005 
NM_053994  Pdha2  Pyruvate dehydrogenase (lipoamide) alpha 2  
> 
GO:0004739 
Pyruvate 
dehydrogenase 
activity 
0.006 
NM_001108898  Ddx28  DEAD (Asp-Glu-Ala-Asp) box polypeptide 28  
> 
GO:0042645 
Mitochondrion 
nucleoid 
0.009 
NM_001013431  Chchd4  Coiled-coil-helix-coiled-coil-helix domain containing 4  
> 
GO:0006626 
Protein targeting to 
mitochondria 
0.012 
NM_053970  Nln  Neurolysin (metallopeptidase M3 family)  
> 
GO:0005739 Mitochondrion 
0.031 
NM_017254  Htr2a  5-hydroxytryptamine (serotonin) receptor 2A  
> 
GO:0006816 Calcium ion transport 
0.031 
 
 
Table S1. Differentially expressed genes between high- and low-anxious rats 
identified in the custom-curated mitochondrial gene sets following gene enrichment 
analysis. P-values were obtained from a general linear model of anxiety and gene 
expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 2: Mitochondrial density and length in high- and low-anxious rats 
Measurement HA LA p-value 
Total Density (per µm2) 0.75±0.05 0.70±0.06 0.53 
Density within dendrites (per µm2) 0.50±0.04 0.50±0.05 0.98 
Total Length (µm) 438.3± 17.3 423.5± 25.7 0.66 
 
 
 
Table S2. Total mitochondrial density, density within dendrites and total mitochondrial 
length in the nucleus accumbens measured in images captured by electron 
microscopy did not differ between high- (HA) and low-anxious (LA) rats. Density is 
presented as mean mitochondria per µm2 ± SEM (Student’s t-test). Length is 
presented as mean µm per 1500 mitochondria ± SEM (Student’s t-test). In the lower 
panel, a TEM representative image highlighting mitochondria with internal inserts is 
shown. 
 
 
 
  
Supplementary Table 3: Effects of anxiety and NAc treatments on other social behaviors 
Dyad Composition Condition Social Investigation (s) 
p-
value 
Auto-grooming (s) 
p-
value 
HA Basal 128.3 ± 10.0 
0.94 
41.1 ± 6.7 
0.57 
LA Basal 129.5 ± 12.5 36.2 ± 5.9 
Matched 
ROT 156.9 ± 23.0 
0.36 
87.9 ± 20.6 
0.39 
DMSO 129.2 ± 24.2 56.7 ± 20.2 
Matched 
MA 122.1 ± 16.5 
0.83 
46.5 ± 10.6 
0.49 
Saline  134.8 ± 18.5 42.8 ± 9.6 
Matched 
3NP 161.4 ± 23.4 
0.57 
51.0 ± 9.6 
0.91 
Saline 164.6 ± 21.3 64.8 ± 13.7 
HA NAM 143.5 ± 29.0 
0.47 
72.8 ± 17.4 
0.89 
HA Saline 118.8 ± 16.4 76.2 ± 23.2 
Matched 
MUS 107.5 ± 27.5 
0.02 
43.7 ± 15.5 
0.89 
Saline 211.1 ± 27.5 40.3 ± 16.9 
 
Table S3. The specificity for each of the pharmacological treatments given intra-NAc 
on social competition was investigated by measuring the total duration of social 
investigation and auto-grooming during the social encounter. Dyads consisted of either 
high- and low-anxious (HA, LA respectively) rats or anxiety-matched rats (Matched). 
Abbreviations: ROT, rotenone; DMSO, dimethylsulfoxide; 3NP, 3-nitropropionic acid; 
MA, malonic acid; NAM, nicotinamide; MUS, muscimol. Data are presented as mean 
± SEM (Student’s t-test).  
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